End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,710 KRW | +0.22% | -1.01% | -12.40% |
Business Summary
Number of employees: 655
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 383,811 | 100.0 % | 370,537 | 100.0 % | -3.46% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
61.2
%
| 209,560 | 54.6 % | 226,906 | 61.2 % | +8.28% |
Overseas
38.8
%
| 174,251 | 45.4 % | 143,631 | 38.8 % | -17.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dong-Yeon Kim
CEO | Chief Executive Officer | 73 | - |
Yoo-Seok Chung
CEO | Chief Executive Officer | 47 | - |
Gyoo-Young Choi
BRD | Director/Board Member | 66 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yoo-Seok Chung
CEO | Chief Executive Officer | 47 | - |
Dong-Yeon Kim
CEO | Chief Executive Officer | 73 | - |
Gyoo-Young Choi
BRD | Director/Board Member | 66 | - |
Seung-Yeol Gong
BRD | Director/Board Member | 64 | 20-03-19 |
Kwang-Soo Joo
BRD | Director/Board Member | 68 | 20-03-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,085,664 | 12,896,736 ( 67.57 %) | 1,113,885 ( 5.836 %) | 66.03 % |
Stock B | 0 | 445,080 | 0 | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
998,805 | 5.23% | 10,631,660 $ |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-12.40% | 179M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- A007570 Stock
- Company Ilyang Pharmaceutical Co.,Ltd